Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial

Autor: Horan, John T., Haight, Ann, Dioguardi, Jacqueline Lagerlof, Brown, Clark, Grizzle, Audrey, Shelman, Chiani, Kanter, Julie, Hale, Greg, Nieder, Michael, Benton, Melody, Kasow, Kimberly A., Abraham, Allistair, Chiang, Kuang-Yueh
Zdroj: In Biology of Blood and Marrow Transplantation May 2015 21(5):900-905
Databáze: ScienceDirect